Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

DNA analysis company 23andme has been in trouble lately: data was breached in a 2023 hack, and this September the entire ...

DNA submitted by users to the genealogy company 23andMe will remain private for now, with CEO Anne Wojcicki saying she no ...

After 23andMe’s board of directors resigns, the president of encrypted messaging app Signal joins other security experts in ...

23andMe is in trouble. Once a hot Silicon Valley startup, the genetic testing company has been in free fall since a major ...

In a report released today, Peter Welford from Jefferies maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmithKline's venerable vaccine Priorix for sale in the US looks timely. Priorix was first launched in Europe ...

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...

GSK turned the mobile phone into a disease detection and risk evaluation tool to raise awareness of under-diagnosed and under-treated chronic obstructive pulmonary disease in China. GSK has always ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

"My life was hell": Man awarded £160,000 damages after Parkinson's drug turned him into gay sex and gambling addict ...